Concurrent and reactivation of hepatitis B virus infection in diffuse large B-cell lymphoma: risk factors and survival outcome

Table 2 Proportion of patients with Response to chemotherapy

Response to chemotherapy	Diffuse large B-cell lymphoma		P value
Response to chemotherapy	HBsAg-positive	HBsAg-negative	P value
Sample size	80	166
Response			< 0.001
Complete response	29 (36.2%)	106 (63.9%)
Partial response	15 (18.8%)	28 (16.9%)
Stable disease	1 (1.2%)	2 (1.1%)
Progress disease	35 (43.8%)	30 (18.1%)

ISSN: 1750-9378